Oruka Therapeutics (ORKA) Capital Expenditures (QoQ) (2011 - 2026)
Oruka Therapeutics (ORKA) Capital Expenditures (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.87% |
| Dec 31, 2025 | -36.36% |
| Sep 30, 2025 | 191.18% |
| Jun 30, 2025 | 161.54% |
| Sep 30, 2021 | -200.00% |
| Jun 30, 2021 | -66.67% |
| Sep 30, 2020 | 100.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 50.00% |
| Mar 31, 2018 | 0.00% |
| Jun 30, 2016 | 4,128.57% |
| Mar 31, 2016 | -96.53% |
| Dec 31, 2015 | 10,000.00% |
| Sep 30, 2015 | -60.00% |
| Jun 30, 2015 | 150.00% |
| Mar 31, 2015 | -97.85% |
| Dec 31, 2014 | -79.19% |
| Dec 31, 2013 | -63.64% |
| Sep 30, 2013 | 37.50% |
| Jun 30, 2013 | -11.11% |